Categories
Report

bhat

Blue Hat (NASDAQ:BHAT)

________________________

‍Hello Everyone,

We couldn’t be more excited to roll out the profile on this next company with gold hitting all time highs again today. It has been an incredible for the world’s favorite precious metal. Right now we are seeing the perfect storm for golds impressive move with worldwide economic uncertainty, interest rates out of control, inflation tearing countries apart and the threat of WW3 or the like looming.

Gold is up over 30% the past year, making it one of the more attractive additions to a portfolio over real estate given the Curren market conditions.

Gold companies have been able to capitalize on this historic move as well.

There is one company that we want you to research before the open Thursday.

Pull up BHAT right away.

You need to research this one immediately.

It has closed green 4 sessions in a row and 6 of the last 7.

Blue Hat’s innovative approach to the gold market sets it apart from traditional players. Unlike established mining juggernauts such as Newmont, Barrick Gold, Agnico Eagle Mines, and Kinross Gold, which generate revenue primarily through gold extraction and processing, Blue Hat is focusing on optimizing the entire lifecycle of gold. The company is leveraging its technological expertise to develop an intelligent gold supply chain and recycling system, encompassing everything from sourcing and recycling to trading and supply chain management. This holistic approach positions Blue Hat as a comprehensive service provider within the gold industry.

Blue Hat is integrating Artificial Intelligence to enhance its offerings, including an intelligent gold supply chain and recycling system (earning the nickname “a virtual gold mining machine”), as well as a sophisticated gold derivatives trading platform, giving it multiple revenue channels.

The company has operations in Hong Kong, Shuibei, Shenzhen and Dubai. BHAT specializes in sourcing, refining, and trading high-quality gold. The company’s wholly-owned Hong Kong subsidiary, Golden Alpha Strategy Ltd., was recently granted Dealers in Precious Metals and Stones Category A Registration by Hong Kong Customs and Excise Department. This regulatory system, implemented by the Hong Kong government aims to combat criminal activities, with only highly vetted companies receiving the coveted designation.

In addition to sourcing gold directly from miners and gold exchanges, they are actively involved in the gold recycling sector. Their advanced gold recycling pricing algorithm, developed in partnership with leading industry experts, enables them to monitor real-time gold price fluctuations and predict market trends with precision. This sophisticated tool allows them to optimize both the pricing and quantity for gold recycling, ensuring maximum value and efficiency.

Upon acquiring gold, they extend their services to include gold leasing, leveraging our strategic position within the Shenzhen Shuibei gold market—a pivotal hub where over half of China’s gold transactions take place. Their gold leasing services cater to a diverse clientele, including gold processing factories, wholesalers, and retailers. They supply these industry participants with high-quality gold and share in the profits derived from the sale of finished gold products, fostering mutually beneficial partnerships and driving profitability.

One of the key components of Blue Hat’s strategy is its focus on digital trading solutions. These platforms allow traders to engage in the gold market without the need for physical storage or insurance, providing greater flexibility and the ability to capitalize on price movements efficiently. High liquidity on these platforms enables traders to swiftly enter and exit positions, contributing to the overall fluidity of the market—an advantage that could see Blue Hat profit in ways similar to the leading upstream players.

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Subsidiary Golden Alpha Strategy Ltd Secures Class A License for Precious Metals and Gem Trading

HONG KONG, June 05, 2024 (GLOBE NEWSWIRE) — Blue Hat Interactive Entertainment Technology, a NASDAQ listed company (hereinafter referred to as “BHAT”), recently announced that its wholly-owned Hong Kong subsidiary, Golden Alpha Strategy Ltd., has been granted Dealers in Precious Metals and Stones Category A Registration by Hong Kong Customs and Excise Department. This regulatory system, implemented by the Hong Kong government on April 1, 2023, aims to combat money laundering and terrorist financing activities. BHAT actively responds to the Hong Kong government’s policy initiative, committing itself to conducting and facilitating commodity trading of precious metals and stones under legal and compliant conditions in Hong Kong and internationally.

Mr. Chen Xiaodong, CEO of BHAT, stated: “We are honored to receive this significant international license, marking a crucial step in our business transformation and international development. This not only demonstrates our commitment to our corporate transformation but also underscores our dedication to conduct international business while fully complying with local and international laws. Moving forward, we will actively expand our business in precious metals, striving to bring more returns to our investors.”

Mr. Chen Xiaodong further added: “With the support of this license, we will closely collaborate with Macau Rongxin Precious Metals Company to advance an innovative intelligent gold supply chain and recycling system, providing gold traders with more efficient, convenient, and secure transactions and better service experiences.”

BHAT continues to emphasize innovation, optimize corporate structure and seek new growth points. The company has successfully expanded its business scope to bulk trading of gems and precious metals. In the future, BHAT will commit itself to leveraging artificial intelligence technology to facilitate commodity trading, especially in the precious metals sector.

Blue Hat Announces Financial Results for the Fiscal Year 2023, of which the Revenue Increased by 33 Times

XIAMEN, China, April 30, 2024 (GLOBE NEWSWIRE) — Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT), primarily a company of commodity trading in China, today announced its audited financial results for the fiscal year ended December 31, 2023 (“Fiscal Year 2023”), reflecting a remarkable surge in the revenue.

Fiscal Year 2023 Financial Highlights

Blue Hat achieved a revenue of $73.68 million in 2023, increasing 33 times than the previous year. This extraordinary achievement is credited to the company’s robust expansion of its commodity trading business, particularly in the realms of jewelry and gold trading, since the fourth quarter of 2022. However, despite the substantial revenue growth, the company incurred a net loss of $21.72 million for the Fiscal Year 2023. The primary reasons for the loss include bad debts and asset impairment resulting from divested businesses. Notably, the Company’s new business line, commodity trading, contributed a profit of nearly $1.2 million to the company for the Fiscal Year 2023.

Management Commentary

Mr. Chen Xiaodong, CEO of Blue Hat, stated at the Company’s annual summary meeting: “Our achievements in 2023 represent not only a breakthrough in financial data, but also a resounding affirmation of Blue Hat’s business strategy transition. In 2024, we will continue leveraging on the technology and experience we have accumulated in past few years. We will deepen our commodity trading in jewelry, especially the diamond and gold trading, and meanwhile expanding online gold derivatives trading, which aim to deliver excellent performance and reward our investors. Furthermore, we are committed to embracing the era of artificial intelligence and inspired to set a new benchmark as a ‘smart’ gold trader.”

Fiscal Year 2023 Financial Results

Please refer to Blue Hat’s annual report on Form 20-F for the fiscal year ended December 31, 2023 filed with the Securities and Exchange Commission on April 30, 2024 for a detailed analysis of Blue Hat’s financial results.

‍NEWS

MANAGEMENT TEAM

‍

‍

XiaoDong Chen

Co-Chief Executive Officer & Director

Mr. Chen Xiaodong, EMBA, has more than 30 years of management experience in large and medium-sized enterprises, and has been deeply engaged in manufacturing, import and export trade, culture and communication, entertainment and technology industries, and is good at corporate strategic planning, corporate culture shaping, team building, and in 2015, he founded the Blue Hat Interactive Entertainment Technology Company Limited, which was successfully listed in the United States.

Guo Fan

Co-Chief Executive Officer & Director

Mr. Guo Fan has over 20 years of investment and transaction experience. Prior to becoming CEO, Mr. Guo was CEO of PAYI, a NASDAQ-listed online payment technology company,and a partner at Frontline Capital Asia Pacific, where he and his partners founded Fluency Capital, a quantitative trading firm in the U.S. in 2009.

Gang Yu

Dr. Yu has over 20 years of financial experience in the global financial industry, having worked as a researcher at J.P Morgan and as a strategy analyst at Goldman Sachs (Asia), Director and Principal of Strategic Asset Management Limited, whose company owns Hong Kong License Plate No. 4 and 9.Dr. Yu has a Ph.D. in Finance from New York University and an M.A. in Economics from the State University of New York.

Di Liu

Dr. Di Liu has many years of research experience and has published several highly cited academic papers and won awards. She has worked as a senior AI algorithm engineer in Aliscompany, and co-founded the “Hongzhan Huichuan No. 1” private equity fund, which is mainly responsible for quantitative algorithmic research. Dr. Di Liu holds a bachelor’s degree from SunYat-sen University and received her PhD in Engineering from Washington University in St.Louis and Virginia Commonwealth University.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SEVEN THOUSAND FIVE HUNDRED USD BY EDM MEDIA LLC FOR A ONE DAY BHAT AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

Categories
Report

SYTA August

READ THE COMPANY PRESENTATION HERE

___________________________

Hello Everyone,

We have another urgent situation for you to take a look at.

We have another company that is announcing earnings at 8:30 am Friday.

Pull up SYTA immediately.

This one just had a reverse split happen at the beginning of the month.

This could have a major impact on this one in the immediate future because the float is now just 800k post split according to Finviz.

Need I say more?

Couple that with numbers coming out before the open and we could have something worth paying attention too if the numbers fall on the right side of expectations.

Siyata Mobile Inc. (NASDAQ: SYTA) is a leading global developer and provider of Push-to-Talk Over Cellular (“PTT/PoC”) systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world’s first 3G connected vehicle device as well as the world’s first 4G/LTE vehicle-mounted smartphone for First Responders and commercial fleets and vehicles, thereby creating a new category in the cellular device market with a dedicated smartphone tailor-made for the commercial vehicle market.

Siyata’s suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company’s flagship product, the Uniden UV350, is the world’s first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada’s largest LTE network and PTT community, as well as AT&T in the U.S. Further expanding its availability, Siyata is completing network approval with another U.S. Tier 1 operator to launch the UV350 in Q3 2019.

Despite Siyata’s small size, no other competitor offers as comprehensive of a portfolio of products. Siyata Mobile Inc. (Nasdaq: SYTA) provides disruptive solutions aimed at the Push-to-talk-over-Cellular (PoC) industry, with three complementary product categories targeted to the same core channels and customers. Large global telecommunications customers provide potential rapid entry into a $50 billion North American market.

Siyata Mobile SD7 Mission Critical Push to Talk Over Cellular Device Featured

UScellular Keeps Business and Government Customers Connected with Intuitive Mission Critical Push to Talk Solution

“Siyata’s SD7 rugged Mission Critical Push to Talk over cellular radio handset is an industry leading device that offers UScellular business customers an alternative to land-mobile radios,” By Kim Kerr, senior vice president, enterprise sales and operations for UScellular.

While State And Local Budgets Experience A Squeeze, Siyata Mobile Provides Police With Affordable And Modern Communication Technology

Siyata’s unique approach of offering an affordable mission-critical PTT over Cellular handset that looks and operates like a two-way radio may allow first responder agencies to equip more of their staff than ever before with a reliable and easy-to-use handset to keep more staff connected. With a track record as a pioneer in the industry and with solutions catering to various uses in areas with and without strong cellular coverage, Siyata has earned a solid reputation for reliability and versatility. With rising budget cuts, this maybe solution that state and local governments are looking for.

As a leading developer and distributor of cutting-edge Mission Critical Push to Talk Over Cellular (PoC) devices, including its flagship products, the SD7 Handset and VK7 Vehicle Kit, Siyata is aiming to revolutionize the way industries worldwide connect and collaborate.

In a rapidly evolving landscape, the SD7 Handset stands out to us as the pinnacle of next-generation communication solutions. Designed to seamlessly integrate with existing systems while offering unparalleled functionality, the SD7 stands to bridge the gap between traditional two-way radios and modern cellular networks. Its reportedly rugged design, military-standard durability, and nationwide coverage is designed to ensure reliability and effectiveness across various verticals, from first responders to construction teams.

Complementing the SD7 is Siyata’s innovative VK7 Vehicle Kit, working to transform any vehicle into a mobile communication hub. With its reportedly seamless integration, robust features, and reliable connectivity, the VK7 is designed to enhance safety and efficiency for commercial fleets, emergency responders, and more.

According to Siyata Mobile, it’s not just disrupting the market; it’s setting new standards for communication excellence. With a track record of exponential growth, a strong presence in key global markets, and a visionary leadership team, we see this as an attractive investment for investors interested in the future of communication technology

Top Reason to have SYTA on your radar

  • Market Disruption: Siyata Mobile (NASDAQ: SYTA) is poised to disrupt the multi-billion-dollar Land Mobile Radio (LMR) industry with its cutting-edge Mission Critical Push to Talk Over Cellular (PoC) technology
  • Next-Gen Communication: With the SD7 and VK7, Siyata offers next-generation communication solutions that bridge the gap between traditional two-way radios and modern cellular networks.
  • Innovative In-Vehicle Solutions: The VK7 Vehicle Kit is designed to transform any vehicle into a mobile communication hub, enhancing safety and efficiency for commercial fleets and emergency responders
  • Global Reach: Siyata operates in key geographies including the United States, Canada, Europe, Australia, and the Middle East, offering solutions tailored to diverse market needs.
  • Rapid Industry Growth: The Mission Critical Push to Talk Over Cellular (PoC) industry is experiencing rapid growth, with a forecasted global PoC growth of approximately 9.4% CAGR, reaching approximately $6.95 billion by 2027
  • Strong Market Position: With a full-year 2023 revenue of $8.2 million, up 27% year-over-year, Siyata demonstrates its ability to capture market share and deliver consistent growth.
  • Comprehensive Product Portfolio: From rugged handsets to in-vehicle devices, Siyata offers a comprehensive product portfolio to cater to the communication needs of various industries, including first responders, hospitals, schools, security, construction, and hospitality
  • Visionary Leadership: Led by CEO Marc Seelenfreund and a seasoned management team, Siyata is guided by a vision of innovation, excellence, and market leadership in communication technology
  • High Growth Earnings: SYTA is expected to become profitable in the coming quarters.
  • High Growth Revenue: SYTA’s revenue is forecast to grow dramtically in 2024 and beyond
https://twitter.com/SiyataMobile/status/1777432316081586616?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1777432316081586616%7Ctwgr%5E22058c213285ae43e3f8cb04547bc6e9543266f0%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Fwww.insiderfinancial.com%2Fprofile%2Fsyta-august

SD7: A Game-Changer in Mission Critical Push to Talk Over Cellular Technology!

SIYATA SD7

Siyata Specializes in Rugged PTT Handsets: SD7 is its Next Generation PoC Handset Complementing its Portfolio of Disruptive Handsets

THE SD7 IS A GAME CHANGER

A Perfect Upgrade from land mobile radio (LMR):

  • forwardA simple, purpose built, highly functional and rugged Android-based PTT only handset
  • forwardRugged IP68 rated design protects against dust and debris
  • forwardExcellent sound quality allowing for clear communication in the presence of background noise
  • forwardAll the benefits of PoC without the headaches of managing the current generation of rugged smartphones and feature phones
  • forwardRobust Next Gen 5G product portfolio coming

VERIZON LAUNCHES SIYATA SD7 AS PART OF ITS STOCKED HANDSET PORTFOLIO

PR Newswire

VANCOUVER, BC , July 26, 2024 /PRNewswire/ — Verizon, in collaboration with Siyata Mobile Inc., is proud to announce the launch of the Siyata SD7, a purpose-built, mission-critical push-to-talk device designed to help revolutionize communication for first responders and enterprise clients across the United States.

Siyata Mobile Inc. (PRNewsfoto/Siyata Mobile Inc.)

Cory Davis , vice president of Verizon Frontline, commented, “We are excited to bring the Siyata SD7 directly to our customers. As the nation’s number one network choice in public safety, Verizon Frontline is committed to providing cutting-edge technology that supports the critical work of first responders. This device is a potential game-changer for first responders and enterprise clients, providing a rugged, easy-to-use ‘cellular radio’ solution that delivers excellent coverage, improved functionality and low start-up and operating costs.”

Marc Seelenfreund , CEO of Siyata, commented, “We are extremely optimistic about the opportunities for the SD7 handset as a stocked item by Verizon. We are confident that the Verizon sales teams will hit the ground running and help convert traditional radio users over to Verizon’s Push to Talk Plus solution, while allowing them to operate on Verizon’s superior cellular network.”

Key features of the Siyata SD7 include:

  • Mission-Critical Push-to-Talk (MCPTT): The Siyata SD7 is designed for mission-critical communication, providing first responders and enterprise clients with the reliability and functionality they need to stay connected in any situation.
  • Purpose-Built for First Responders: The Siyata SD7 is purpose-built “cellular radio” for first responders, with a rugged design that can withstand the rigors of the field. It is also equipped with advanced features such as an emergency button and GPS tracking to ensure the safety and security of those in the line of duty.
  • Seamless Integration with Verizon Frontline: The Siyata SD7 is fully integrated with the Verizon network, providing users with access to an award-winning network.
  • Low Start-Up and Operating Costs: With superior coverage, improved functionality and low start-up and operating costs, the Siyata SD7 is a cost-effective solution for first responders and enterprise clients.

About Verizon

Verizon Communications Inc. (NYSE, Nasdaq: VZ) powers and empowers how its millions of customers live, work and play, delivering on their demand for mobility, reliable network connectivity and security. Headquartered in New York City , serving countries worldwide and nearly all of the Fortune 500, Verizon generated revenues of $134.0 billion in 2023. Verizon’s world-class team never stops innovating to meet customers where they are today and equip them for the needs of tomorrow. For more, visit verizon.com or find a retail location at verizon.com/stores .

About Siyata Mobile

Siyata Mobile Inc. (Nasdaq: SYTA) is a B2B global developer and vendor of next-generation Push-To-Talk over Cellular handsets and accessories. Its portfolio of rugged PTT handsets and accessories enables first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice, to increase situational awareness and save lives. Police, fire, and ambulance organizations as well as schools, utilities, security companies, hospitals, waste management companies, resorts and many other organizations use Siyata PTT handsets and accessories today.

In support of our Push-to-Talk handsets and accessories, Siyata also offers enterprise-grade In-Vehicle solutions and Cellular Booster systems enabling our customers to communicate effectively when they are in their vehicles, and even in areas where the cellular signal is weak.

Siyata sells its portfolio through leading North American cellular carriers, and through international cellular carriers and distributors.

NEWS

Wed Aug 14th, 2024

Tue Aug 13th, 2024

  • SIYATA MOBILE TO HOST SECOND QUARTER 2024 FINANCIAL RESULTS CALL AT 8:30 A.M. ET ON AUGUST 16, 2024

Mon Aug 12th, 2024

Wed Jul 31st, 2024

Tue Jul 30th, 2024

Fri Jul 26th, 2024

Thu Jul 25th, 2024

Mon Jul 22nd, 2024

Thu Jul 18th, 2024

Mon Jul 15th, 2024

Wed Jul 10th, 2024

Mon Jul 8th, 2024

Tue Jul 2nd, 2024

Fri Jun 28th, 2024

Thu Jun 27th, 2024

Wed Jun 5th, 2024

  • SIYATA MOBILE ANNOUNCES NEW PARTNERSHIP WITH JD TELECOM

Thu May 30th, 2024

Tue May 28th, 2024

Thu May 23rd, 2024

Wed May 22nd, 2024

Tue May 21st, 2024

Thu May 16th, 2024

Wed May 15th, 2024

Tue May 14th, 2024

‍

MANAGEMENT TEAM


Marc Seelenfreund – CEO

Founder and CEO of Siyata . Prior to establishing Siyata Mr. Seelenfreund was a VP at Sunrise Corporation in New York focusing on financing publicly traded technology companies. Mr. Seelenfreund has a law degree and is a board member at a leading private university.

Gerald Bernstein – CFO

Mr. Bernstein spend 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. Mr. Bernstein holds a Bachelor of Commerce as well as a Graduate Diploma in Public Accountancy- both from McGill University. Member of the Canadian Institute of Chartered Accountants since 1987 and a professional chartered accountant.

Glenn Kennedy – VP Sales

Mr. Kennedy has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Mr. Kennedy has managed sales nationally for Motorola Canada, HTC Communications Canada and Sonim Technologies. Mr. Kennedy holds an Bachelor of Arts in Honors Business Administration from the Richard Ivey School of Business at the University of Western Ontario

GARY HERMAN – Chairman of the Board

Mr. Herman has several decades of experience as a sophisticated public company investor, fund manager and investment banker. Over the course of his career, he has served on both public and private company boards of directors and has also been a corporate officer, capital raiser, and restructuring specialist.
Mr. Herman currently serves on the Board of Jupiter Wellness, Inc. (NASDAQ: JUPW); XS Financial, Inc. (CSE: XS), and SusGlobal Energy Corp. (OTCQB: SNRG).

Stephen Ospalak, Board Member

Over 20 years in telecom, currently SVP Marketing & Operations at BMG Inc. Served as interim CEO for AiTelecom; Global Integration Officer for Virgin Management Inc.; Canadian VP & Board Advisor for Brightstar, and as SVP Operations at Iusacell. Served as VP of Products & Services at Telus Communications Inc. responsible for an annual spend > $US 1billion in wireless & wireline equipment. Led the planning and execution of Clearnet’s market debut and nationwide launch of the iDEN and PCS Cellular services, setting the North American PCS launch record. Held management positions at AT&T.

Lourdes Felix, Board Member

Lourdes Felix is a corporate finance executive offering over fifteen years of combined experience in public accounting and in the private sector in building, leading, and advising corporations through complex restructurings. Ms. Felix was previously the controller for a mid-size public accounting firm for over seven years and was responsible for the operations and financial management of regional offices. Ms. Felix has been a Director of BioCorRx Inc. since March 7, 2013. Ms. Felix was appointed Chief Executive Officer of BioCorRx on November 9, 2020 and became Chief Financial Officer of BioCorRx on October 1, 2012. Ms. Felix was President of BioCorRx from February 26, 2020 until she resigned upon her appointment as CEO on November 9, 2020. Ms. Felix holds a Bachelor of Science degree in Business Management and Accounting from University of Phoenix.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SEVEN THOUSAND USD BY SICA MEDIA LLC FOR A ONE DAY SYTA AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

Categories
Report

SRFM

SRFM was the largest commuter airline in the US by scheduled departures, flying over 450,000 passengers on ~75,000 flights to 48 destinations in the US in 2022

READ THE LATEST STAT SHEET HERE

_______________________

Hello Everyone,

We have SRFM back on our radar for tomorrow’s session.

This is one that we profiled back in January when we saw it run double digits on the day we had you watch it.

Surf Air Mobility is a Los Angeles-based regional air mobility platform expanding the category of regional air travel to transform flying through the power of electrification. In an effort to substantially reduce the cost and environmental impact of flying and as the owner of the largest commuter airline in the US, Surf Air Mobility intends to develop powertrain technology with its commercial partners to electrify existing fleets and bring electrified aircraft to market at scale. The management team has deep experience and expertise across aviation, electrification, and consumer technology.

A lot has happened with the company since the last time we put it in front of you.

Just today the company came out with massive news regarding an agrement with AI giant Palantir.

This news was well received on the street, shooting it up all the way to .42 on well above average interest.

It has pulled back a bit off of the highs, giving investors another shot at looking at this one with this massive news still in play.

Earlier this morning Surf Air Mobility filed an 8-K that outlined plans to form a new venture, Surf Air Technologies LLC, and an agreement with Palantir Technologies, Inc. Pursuant to the Agreement, Surf Air Mobility will establish Surf Air Technologies LLC, a subsidiary of Surf Air Mobility to develop, market, sell, maintain, and support an artificial intelligence-powered software platform for the advanced air mobility industry, which will be powered by Palantir, to provide operators of all types of aircraft, amongst other software products and solutions, with systems for the management of planes, airline operations, and customer facing applications.

Palantir logo (PRNewsfoto/Palantir Technologies)

Surf Air Mobility will contribute its software, intellectual property, and operational data, along with its development team, to support the creation and operation of the new AI-powered platform, SurfOS. Palantir, in turn, will provide implementation engineering services through its platforms, including Foundry and AIP.

Surf Air Technologies LLC will also seek not less than $5 million in initial funding from third-party investors, sourced by both Surf Air Mobility and Palantir. The transactions under the JV Agreement are anticipated to close by November 30, 2024, pending several conditions: the formal establishment of Surf Air Technologies as a Delaware LLC, the signing of its operating agreement, contributions from both parties, securing outside capital, and internal approvals from both companies.

Under the terms of the agreement, Surf Air Mobility will have the right to designate four of the five members on the board of Surf Air Technologies, including the Chair, legal representative, and General Manager, while Palantir will appoint one board member. The agreement also provides both companies with strategic rights, including pre-emptive rights on capital increases, first refusal rights on equity transfers, and options for equity exchanges in various scenarios.

This agreement with Palantir is a significant move for Surf Air Mobility, potentially setting the stage for a major disruption in the advanced air mobility sector. Since their collaboration began in 2021, SRFM has been focused on creating a cutting-edge solution to address the fragmented and outdated software currently available to regional air operators. With the development of SurfOS, the two companies are poised to deliver a comprehensive, AI-powered platform that could revolutionize regional air operations.

Given Palantir’s stellar reputation and the strategic importance of this collaboration, the potential impact on Surf Air Mobility is enormous.

Surf Air Mobility’s release of Q2 2024 financial results, scheduled for Wednesday after the market close, will be closely watched, especially in the wake of this major announcement.

‍

Read the Full Release From Tuesday Here:

Surf Air Mobility Announces Plan to Form New Venture, Surf Air Technologies LLC, and Enters Agreement with Palantir Technologies Inc. to Power Operating System for the Advanced Air Mobility Industry

The companies have been working together since 2021 deploying operator software used by Surf Air Mobility. Surf Air will leverage Palantir’s AIP to build a unique and transformative set of software tools for regional air operators and electrified aircraft OEMs.

LOS ANGELES–(BUSINESS WIRE)– Surf Air Mobility (NYSE: SRFM) (“Surf Air Mobility”, “Surf Air”), a leading regional air mobility platform, has announced that it intends to form Surf Air Technologies LLC (“Surf Air Technologies”), a new venture that will develop, market, and sell AI-powered software tools to create a category-defining operating system for the advanced air mobility industry. Surf Air Technologies’ core platform, “SurfOS”, will be powered by Palantir Technologies (NYSE: PLTR) (“Palantir”), a global leader in artificial intelligence, enterprise data analytics, and business intelligence.

Surf Air Technologies intends to sell and deploy software tools across the market consisting of thousands of Part 135 regional air operators (small aircrafts limited to under 30 seats with a 7,500 pound maximum payload), of which Surf Air Mobility’s Southern Airways subsidiary is the largest by scheduled departures. Palantir and Surf Air will engage their enterprise teams to make this technology broadly available.

Surf Air Technologies will build on the successful work Palantir and Surf Air began in 2021, in which the companies have been deploying software and analytics tools for use across Surf Air’s three air travel brands. The tools the companies have developed to date have focused on the most important needs for Part 135 operators and includes crew scheduling, business intelligence, distribution and pricing. Surf Air has already seen improvements to its own operations and business across these categories. For instance, since the start of our partnership, by leveraging deeper insights into customer behavior, preferences, and travel patterns, Surf Air has seen an approximate 25% increase in revenue per trip1 within its On Demand charter division. This work with Palantir has laid the foundation for Surf Air’s platform to be able to host and provide the tools for multiple brands beyond just Surf Air.

Surf Air will be the first customer and consumer for SurfOS, and it plans to use these tools to enhance deployment and utilization of its own electrified aircraft, once certified.

Surf Air is considering bringing in outside investors to capitalize the Surf Air Technologies venture.

“SurfOS powered by Palantir’s Foundry and AI platforms will provide cutting edge AI-powered software infrastructure to operators of scheduled service and charter services, consumers, and aircraft manufacturers not existing today. SurfOS AI-powered operating systems will enable operators across the ecosystem to run their businesses more efficiently with access to more data with all types of aircraft including new electrified aircraft. SurfOS will provide disruptive software services and an operating platform to the advanced air mobility space to manage distribution and operations, enabling new businesses to flourish,” said Sudhin Shahani, Co-founder of Surf Air Mobility.

Surf Air believes that artificial intelligence, machine learning, and big data will transform advanced air mobility and will require a new set of tools to support the growth of this market segment. Surf Air Technologies is focused on addressing the largest opportunities across advanced air mobility, such as dynamic pricing, revenue management, and optimal aircraft and crew utilization.

The software tools will enable more accurate decision-making to improve operational efficiency and drive revenue, and will be categorized across dimensions that include revenue operations, distribution & monetization, and passenger operations.

The potential market opportunity is large, with the FAA reporting 1,818 Part 135 operators with 11,702 aircraft in the U.S. alone. The introduction of new electrified vehicles for passenger and cargo use are anticipated to create a new form of mass transportation with low cost, low emission, point-to-point flying on short-haul, regional routes.

Reports from McKinsey & Co. and NASA estimate that the size of the regional air mobility market could reach between $75 billion and $115 billion by 2035, and a report from Morgan Stanley estimates that the TAM for urban air mobility could reach $1 trillion by 2040 and $9 trillion by 2050.

“We’re excited to offer these software tools to over 300 of the air operator partners we work with most often to empower their businesses and meet the growing demand for more efficient regional connectivity,” said Jamie Strecker, VP of Business Development for Surf Air Mobility.

Q1 2024 Performance

Top Reasons to Research This One

Game-Changing Collaboration: The recent agreement with a leading tech giant is a significant step forward for Surf Air Mobility Inc.. By harnessing cutting-edge AI and data analytics, this collaboration will enable the company to deliver unparalleled operational efficiencies, setting a new standard in the air mobility market.

Massive Market Potential: The regional air mobility market is expected to grow exponentially, with projections suggesting it could reach $115B by 2035. With Surf Air Mobility Inc.’s strategic positioning, they appear well-prepared to capitalize on this immense growth potential.

Optimizing Key Operations: Part 135 operations, which account for over 2.8 Million flight hours in the US in 2023, are a crucial segment of the air mobility industry. Surf Air Mobility Inc.’s new AI-powered software platform is designed to optimize these operations, driving efficiency and innovation across the sector.

Pioneering Sustainable Aviation: Surf Air Mobility Inc. is not only focused on improving operational efficiency but also on sustainability. By developing powertrain technology to electrify smaller existing aircraft, the company is taking significant steps toward decarbonizing air travel. Imagine a future where flying between 50 to 500 miles is not only eco-friendly but also cost-effective—a vision that Surf Air Mobility Inc. is actively working to make a reality.

Strategic Partnerships and Global Reach: Surf Air Mobility Inc. continues to expand its global footprint through strategic deals in places like East Africa and Brazil

Revenue Streams

Surf Air Mobility Inc. (NYSE:SRFM) is revamping travel. They’re not just changing the game; they’re rewriting the playbook with a diverse revenue mix.

Scheduled flights linked 48 US cities in 2022, making travel a breeze. Whether it’s a single seat or a private charter, Surf Air Mobility (with their subsidiary brands, Surf Air, Southern Airways, and Mokulele Airlines) is the go-to for fast, convenient journeys.

Their role in essential air services (EAS) adds consistent, subsidized revenue.

A groundbreaking partnership with Purdue University: subsidized flights between Purdue and Chicago O’Hare were just launched in Q2 2024, transforming travel for Purdue’s community.

In May 2024, Surf Air (NYSE:SRFM) launched another subsidized route connecting Williamsport with Washington Dulles, injecting new life into the regional airport.

Beyond passenger services, Surf Air intends for its Aircraft-as-a-Service (ACaaS) program they’re developing to be a revolution in the skies.

Electric planes and ACaaS are just the beginning

NEWS

Surf Air Mobility Announces Plan to Form New Venture, Surf Air Technologies LLC, and Enters Agreement with Palantir Technologies Inc. to Power Operating System for the Advanced Air Mobility Industry8 hours agoSurf Air Mobility Announces Terms of Reverse Stock Split4 days agoSurf Air Mobility Announces Closing of $35.2 Million Mandatory Convertible Security with GEM Global Yield LLC4 days agoSurf Air Mobility to Provide Second Quarter 2024 Financial Results on August 14, 20247 days agoLouis Saint-Cyr to Become President of Hawai’i Operations for Surf Air MobilityJul 2, 2024Jim Sullivan, Airline Executive, to Become President of Air Mobility for Surf Air MobilityJun 13, 2024Surf Air Mobility Enters Agreement to Supply Electric Powertrains to Asta, a Brazilian Cessna Caravan OperatorJun 11, 2024Surf Air Mobility Presents at Palantir Technologies AIPCon June 2024Jun 6, 2024Surf Air Mobility and Williamsport, Pennsylvania, Officially Begin Subsidized Commuter Air Service Between Williamsport Regional Airport (IPT) and Washington Dulles International Airport (IAD)May 28, 2024Surf Air Mobility Receives Continued Listing Standard Notice from NYSE

May 24, 2024

MANAGEMENT TEAM

Deanna White – Incoming Interim CEO and COO

‍Deanna White brings years of aviation experience and commitment to transforming flight. She served as COO at Kitty Hawk, where she led the business operations and commercialization of an R&D eVTOL aircraft program. She also served as CFO and CEO of Bombardier Flexjet. She holds a BS in accounting from the University of Tampa, and and MBA and MA in Cybersecurity from the University of Dallas.

Sudhin Shahani – Co-Founder

‍Shahani is a seasoned entrepreneur and venture capital investor with a diverse portfolio in aviation, media, technology, and education. He is the co-founder of Surf Air Mobility, where he has been steering the company’s vision, fundraising, and M&A activities since 2014. Under his leadership, Surf Air has raised over $400M and pioneered sustainable flight technologies. Before this, he was an Entrepreneur in Residence at Anthem Ventures, managing over $450M and serving on various boards. Shahani also co-founded Musicane and RTG Animate.

Fred Reid – Head of Global Business Development

A global aviation leader, Fred Reid has built products and services enjoyed by consumers around the world. As the founding CEO of Virgin America, America’s top airline for nearly 10 years, Fred helped create the “next generation airline”. Fred has also served as President of Lufthansa, Delta, Kitty Hawk, and Flexjet, and served as the Global Head of Transportation at Airbnb.

Carl Albert – Chairman

‍Albert boasts extensive experience in aviation, formerly serving as principal investor and Chairman & CEO of Wings West Airlines, acquired by AMR, and later of Fairchild Aircraft for a decade. Under his leadership, Fairchild acquired German manufacturer Dornier Luftfahrt, both companies producing regional aircraft and Dornier supplying Airbus with key components for multiple models. Albert also oversaw Merlin Express, a cargo service for UPS and FedEX. He has managed engineering programs to obtain various aircraft certifications from regulatory bodies like FAA and EASA.

Oliver Reeves – Chief Financial Officer

Oliver Reeves is a seasoned financial executive with a proven track record at both the strategic and operational levels. He will lead Surf Air Mobility’s financial and capital markets strategies, leveraging nearly two decades of experience in the investment management, enterprise technology, and insurance industries. Prior roles include serving as Chief Strategy Officer at Xinuos, Inc. since 2019.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF SEVEN THOUSAND FIVE HUNDRED USD BY LFG EQUITIES CORP FOR A ONE DAY SRFM AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

Categories
Report

LTRN

Lantern Pharma Inc. NASDAQ: LTRN logo small-cap

READ THE INVESTOR PRESENTATION HERE

_________________________________________________

Hello Everyone,

We are back with another biotech for you to research this week.

This one has a catalyst this week that is noteworthy.

The company announced that it will host its second quarter 2024 operating and financial results on Thursday, August 8, 4:30 p.m. EST after the close.

Pull up LTRN right away.

This is another fresh company that is brand new to us here.

You are going to find some impressive technology while you are researching this one.

Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Their proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, they have accelerated the development of their growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, their newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program.

Their lead development programs include two Phase 2 clinical programs. They have also established a wholly-owned subsidiary, Starlight Therapeutics Inc., to focus exclusively on the clinical execution of their promising therapies for CNS and brain cancers, many of which have no effective treatment options. Their AI-driven pipeline of innovative product candidates are estimated to have a combined annual market potential of over $15 billion USD and have the potential to provide life-changing therapies to hundreds of thousands of cancer patients across the world.

LTRN is revolutionizing the fields of oncology drug discovery and development through its proprietary AI and machine learning platform, RADR®. Utilizing an extensive dataset of over 25 billion oncology-centric data points and a library of more than 200 advanced machine learning algorithms, the company addresses multi-billion-dollar challenges in the oncology drug development landscape. With guidance from an elite team of scientific advisors and collaborators, Lantern Pharma has expedited its growing portfolio of treatments. This includes eleven distinct cancer indications as well as an antibody-drug conjugate program. Remarkably, new drug programs propelled by Lantern Pharma’s technology advance from initial AI-derived insights to first-in-human clinical trials within a 2-3 year time frame and at a cost of approximately $1.0-2.0 million per program. The company’s AI-empowered pipeline has an estimated combined annual market potential exceeding $15 billion USD and holds the promise of delivering transformative therapies to hundreds of thousands of cancer patients.

‍

If you back to February and March of this year you will notice that this one took off from 4 Bucks and ran all the way to 12 on above average interest. The float on this one is fairly small at roughly 8 Million. This could be a major factor a to why LTRN was able to take off without notice.

‍

‍

LTRN is sitting at a critical support level as you can see on the 3 month chart above. You can see that back in June this one started to take off from these exact levels and exploded up past 5 bucks. It has already established the potential to move.

RECENT HIGHLIGHTS

Active clinical trials across three AI-guided drug candidates with initial data and clinical readouts for LP-184 on-track for the second half of 2024.Obtained regulatory allowance to begin Phase 2 Harmonic™ clinical trial enrollment in Japan and Taiwan where approximately 30-35+% of all lung cancer cases occur in never-smokers with NSCLC; Harmonic™ continues patient enrollment in the US.Phase 1 clinical trials for both synthetic lethal drug-candidates, LP-184 and LP-284, continue to advance with no dose-limiting toxicities observed in any of the patient cohorts enrolled and dosed to date.The combined annual global sales market potential for LP-184 and LP-284 across multiple cancer indications is estimated to be over $12 billion USD.Starlight Therapeutics, a wholly owned subsidiary of Lantern Pharma focused on CNS and brain cancers with STAR-001, advanced with the filing of a clinical trial protocol for the Phase 1B dose optimization and expansion cohort in recurrent IDH wild-type high grade gliomas.Advanced AI-powered module for streamlining and guiding differentiated ADC development, which will be instrumental in the next-generation of drug candidates for Lantern Pharma and its collaborators.Established an AI driven collaboration with Oregon Therapeutics where the RADR® platform will be leveraged to sharpen, expand and derisk future clinical development strategies for a novel, first-in-class inhibitor of cancer metabolism.Approximately $38.4 million in cash, cash equivalents, and marketable securities as of March 31, 2024.

Lantern Pharma Achieves Key Milestone Towards Development of Molecular Diagnostic for use in Oncology Clinical Trials for Patient Selection and Stratification with Drug Candidate LP-184

DALLAS–(BUSINESS WIRE)– Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence (AI) and machine learning to transform the cost, pace, and timeline of oncology drug discovery and development, today announced a significant advancement towards the development of a diagnostic for its drug candidate LP-184. The diagnostic is currently based on qRT-PCR (quantitative real-time polymerase chain reaction) technology and is focused on quantifying the amount of PTGR1 RNA in patient tumor samples to assess the potential for sensitivity to Lantern’s drug candidate LP-184. The company plans to further develop and validate the assay for its use as a potential tool for patient selection in later stage clinical trials across a broad range of solid tumors that have shown sensitivity to LP-184.

Figure 1: Correlation of PTGR1 expression and cytotoxicity/potency (IC50, µM) of LP-184 (Graphic: Business Wire)

Figure 1: Correlation of PTGR1 expression and cytotoxicity/potency (IC50, µM) of LP-184 (Graphic: Business Wire)

Lantern has successfully confirmed PTGR1 as a key biomarker that it intends to use to optimize patient selection based on potential tumor sensitivity to the drug candidate LP-184. LP-184 is a precision oncology drug candidate with the potential to address multiple solid tumors. This confirmation marks a crucial step towards the development of a companion diagnostic and potential stratification tool to assist with targeted patient selection. Lantern plans on further validations and development of the assay using qRT-PCR and partnering with central labs and cancer centers for eventual use in patient selection and stratification. In a key publication on the utility and value of biomarkers in oncology trials among some of the most common cancers, titled Does biomarker use in oncology improve clinical trial failure risk? A large‐scale analysis by Parker, et al., 2021 in Cancer Medicine found success of clinical trials to be significantly correlated to the incorporation of biomarkers. In particular, the Parker, et al. publication stated that:

“…Our overall analysis of these four cancers, independent of indication, revealed a fivefold benefit of hazard ratios from the Markov models, suggesting a substantial benefit from biomarker use. The hazard ratio analysis of the Markov biomarker models examined how likely clinical trial success was associated with biomarker use versus no biomarker use. Hazard ratios indicated that for biomarker‐based drugs clinical trial success was largest for breast cancer (12‐fold) followed by melanoma (eightfold) and lung cancer (sevenfold) …Our data provide the most extensive look at biomarker use to date in oncology, with an advanced statistical method. Our findings indicate that biomarkers provide a statistically significant benefit, despite the fact our study includes biomarkers not yet FDA approved.”

By incorporating the PTGR1 biomarker into LP-184’s development strategy, Lantern Pharma is aligning with best practices in precision medicine and aiming to increase the likelihood of successful clinical outcomes in future clinical trials. PTGR1 levels have been measured to be higher in certain cancer cells than in normal cells, and Lantern is leveraging this biological activity to target the cancer indications believed most likely to respond to drug candidate LP-184. In the October 2023paper in Molecular Cancer Therapeutics, Lantern along with collaborators from Fox Chase Cancer Center published clear evidence that higher potency of LP-184 (measured in IC50 values) was directly correlated with higher expressions of PTGR1 and that cancer cell lines that did not have PTGR1 expression remained stable in the presence of LP-184 (see figure 1).

“This milestone represents a significant leap forward in our precision oncology approach and in ensuring that we enrich our future LP-184 clinical trials with the patients we believe will be most likely to benefit,” said Panna Sharma, CEO of Lantern Pharma. “By working to develop a companion diagnostic for LP-184, we’re not just advancing a drug candidate; we’re paving the way for more personalized and effective cancer treatments for patients that have the highest likelihood of benefitting from the therapy. The planned use of biomarkers like PTGR1 in our clinical trials exemplifies our commitment to data-driven, patient-centric drug development.”

These steps toward development of this companion diagnostic align with Lantern Pharma’s commitment to leveraging cutting-edge technology in drug development. By combining AI-driven insights with advanced diagnostic tools, the company aims to accelerate the drug development process and improve patient outcomes.

Lantern Pharma plans to implement this assay in upcoming clinical trials for LP-184, potentially streamlining the development process and increasing the likelihood of successful outcomes. LP-184— a novel therapeutic in clinical development for the potential treatment of malignant gliomas, pancreatic cancer, and atypical teratoid rhabdoid tumors (ATRT)— has also been granted an Orphan Drug Designation by the FDA, along with a Rare Pediatric Disease Designation.

NEWS

MANAGEMENT TEAM

‍

Chief Executive Officer, President and Director

Panna Sharma

Passionate about the use of A.I. and machine learning to change the risk, cost, and timelines in the highly interdisciplinary field of personalized medicine.

Passionate about the use of A.I. and machine learning to change the risk, cost, and timelines in the highly interdisciplinary field of personalized medicine.
‍

Panna Sharma is the President, CEO, and Board Member of Lantern Pharma Inc., a clinical-stage oncology biotech using artificial intelligence (AI) and genomics to innovate the rescue, revitalization, and development of precision cancer therapeutics. Lantern is focused on improving patient outcomes by using its proprietary AI platform – Response Algorithm for Drug Repositioning & Rescue (RADR®) – to rescue, revitalize and develop abandoned or failed cancer drugs, and to accelerate their development through precision trials that help identify patient groups more likely to respond to its pipeline of targeted cancer therapies.
‍

As Chief Executive Officer, Panna is responsible for developing Lantern’s strategic vision, and working closely with the venture investors to raise capital that will place the Company at the forefront of using AI and genomics in developing its pipeline of precision therapies. The Lantern Pharma (LP) pipeline currently consists of four drug candidates and an ADC program across 8 tumor targets, including two phase 2 programs, all focusing on cancers that have unique and unmet clinical needs with a clearly defined patient population. These drugs can be targeted to patients whose profile identifies them as having the highest probability of benefiting from the drug, thereby achieving better outcomes with reduced costs and accelerated timelines.
‍

Prior to joining Lantern in 2018, Panna was the President and Chief Executive Officer of Cancer Genetics, Inc. (Nasdaq: CGIX), a provider of genomic and immune-based cancer diagnostics and therapy development services to some of the most prestigious medical institutions and pharma companies in the world. In his capacity as CEO at CGIX, he raised over $100 million in the public and private markets and grew the company from 25 employees in New Jersey to over 250 employees globally across multiple continents. Panna took CGIX public in 2013 and acquired four companies globally that help CGIX deliver on its mission to help personalize cancer treatment. Prior to CGIX, Panna founded TSG Partners, a specialty advisory group combining corporate strategy and corporate finance to create shareholder value for companies and investors in the life sciences, biotechnology, and environmental sciences. Panna began his career as an industry analyst for financial services and technology companies and was part of the management team that took the digital strategy and e-business company iXL public.
‍

Panna attended Boston University in the University Professors Program and focused his studies on Philosophy of Science, Neural Networks and Artificial Intelligence. When not focused on the future of biotech, machine learning, emerging technologies, and genomics, Panna can be found with his three children and wife and listening to music, attending sports functions, discussing new and ethical uses of A.I., debating language theories and enjoying the vibrant and evolving local food scene.
‍

‍

Chief Financial Officer and Secretary

David R. Margrave

Mr. Margrave has served as our Chief Financial Officer since November 2019 and as our Secretary since June 2018. Since January 2016, Mr. Margrave has served as a life science consultant, providing strategic advisory and legal services to growing life science companies.

Mr. Margrave has served as our Chief Financial Officer since November 2019 and as our Secretary since June 2018.  Since January 2016, Mr. Margrave has served as a life science consultant, providing strategic advisory and legal services to growing life science companies.  From January 1995 to December 2015, he served as an executive officer at BioNumerik Pharmaceuticals, Inc., a life science company focused on advancing innovative cancer therapies.  During his time at BioNumerik Pharmaceuticals, Inc., Mr. Margrave served in various positions including service as President and as Chief Administrative Officer and General Counsel.  Mr. Margrave has served as a consultant to BioNumerik Pharmaceuticals, Inc. since January 2016.  From April 2015 to December 2016, he also served as Senior Legal Advisor to MedCare Investment Corporation, a private investment firm investing in the medical and healthcare services industries.  Prior to joining BioNumerik Pharmaceuticals, Inc., Mr. Margrave was a partner at Andrews & Kurth LLP, a national law firm.  Mr. Margrave serves as Chairman and a board member of the Texas Healthcare and Bioscience Institute and as Chairman and a board member of the State of Texas Product Development & Small Business Incubator Board.  He is a past board member of the Texas Technology Transfer Association.  Mr. Margrave received a Bachelor of Arts and Science degree in Economics and in Petroleum Engineering from Stanford University, and a J.D. degree from The University of Texas School of Law.

‍

Chief Scientific Officer

Kishor G. Bhatia, PhD

Dr. Bhatia has served as our Chief Scientific Officer since December 2019, and as our scientific consultant since January 2019. Dr. Bhatia also serves as a scientific consultant to Reprocell, one of our collaborators, since December 2016, and served as a scientific consultant to Cancer Genetics, Inc. from December 2016 until November 2019.

Dr. Bhatia has served as our Chief Scientific Officer since December 2019, and as our scientific consultant since January 2019.  Dr. Bhatia also serves as a scientific consultant to Reprocell, one of our collaborators, since December 2016, and served as a scientific consultant to Cancer Genetics, Inc. from December 2016 until November 2019.  Since 2006, he has been employed as an Adjunct Investigator with the National Cancer Institute-Division of Cancer Epidemiology and Genetics.  From January 2007 until July 2016, Dr. Bhatia also served as a Director-AIDS Malignancy Program at the National Cancer Institute-Office of HIV and AIDS Malignancy, and from January 2004 through January 2007, he served as a Program Director and the Director of the National Cancer Institute-Division of Cancer Treatment and Diagnosis.  Dr. Bhatia received a Bachelor of Science degree in microbiology from the University of Pune and a Ph.D. in biochemistry from the University of Mumbai. He is a Fellow of the Royal College of Pathology in the United Kingdom, was a Post-Doctoral Fellow at Johns Hopkins University and was a Research Assistant Professor at Georgetown University from 1985 to 1989.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF EIGHT THOUSAND USD BY LFG EQUITIES CORP FOR A ONE DAY LTRN AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.